Are cannabinoids an alternative for cachexia-anorexia syndrome in patients with advanced cancer?
Resumen INTRODUCCIÓN La caquexia y la anorexia se encuentran dentro de los síntomas más frecuentes en los pacientes oncológicos. Los cannabinoides han sido propuestos para su manejo en los pacientes con cáncer avanzado, sin embargo, su rol es controvertido. MÉTODOS Para responder esta pregunta...
Main Authors: | Claudia Cabeza, Oscar Corsi, Pedro Pérez-Cruz |
---|---|
Format: | Article |
Language: | English |
Published: |
Medwave Estudios Limitada
2018-12-01
|
Series: | Medwave |
Online Access: | https://www.medwave.cl/link.cgi/Medwave/PuestaDia/ResEpis/7130 |
Similar Items
-
Anorexia-cachexia syndrome in cancer patients: pathogenetic aspects and treatment options
by: A. V. Snegovoy, et al.
Published: (2020-12-01) -
A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
by: Ivy O. Poon, et al.
Published: (2024-02-01) -
Megestrol acetate in cancer cachexia and anorexia: Tertiary care experience
by: Kaneez Fatima, et al.
Published: (2021-01-01) -
IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment
by: Iftekhar Hossain Chowdhury, et al.
Published: (2024-05-01) -
Mirtazapine versus Megestrol in the Treatment of Anorexia–Cachexia Syndrome in Patients with Advanced Cancer: A Randomized, Double-Blind, Controlled Phase II Clinical Trial
by: Olga Laura Sena Almeida, et al.
Published: (2023-07-01)